Wave Life Sciences Ltd (NASDAQ: WVE) kicked off on Monday, up 5.01% from the previous trading day, before settling in for the closing price of $9.59. Over the past 52 weeks, WVE has traded in a range of $4.25-$16.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 607.85% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -36.93%. With a float of $122.55 million, this company’s outstanding shares have now reached $153.04 million.
In an organization with 288 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 60.69%, operating margin of -101.94%, and the pretax margin is -89.57%.
Wave Life Sciences Ltd (WVE) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Wave Life Sciences Ltd is 20.15%, while institutional ownership is 79.46%. The most recent insider transaction that took place on Mar 20 ’25, was worth 102,574. In this transaction Director of this company sold 10,500 shares at a rate of $9.77, taking the stock ownership to the 16,115 shares. Before that another transaction happened on Mar 20 ’25, when Company’s Director proposed sale 10,500 for $9.77, making the entire transaction worth $102,579.
Wave Life Sciences Ltd (WVE) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -36.93% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 34.49% during the next five years compared to 34.27% growth over the previous five years of trading.
Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators
Take a look at Wave Life Sciences Ltd’s (WVE) current performance indicators. Last quarter, stock had a quick ratio of 2.89. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -0.97 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd (WVE)
Let’s dig in a bit further. During the last 5-days, its volume was 0.86 million. That was inferior than the volume of 0.96 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 36.54%. Additionally, its Average True Range was 0.69.
During the past 100 days, Wave Life Sciences Ltd’s (WVE) raw stochastic average was set at 18.37%, which indicates a significant decrease from 51.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 74.71% in the past 14 days, which was higher than the 66.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.91, while its 200-day Moving Average is $9.72. However, in the short run, Wave Life Sciences Ltd’s stock first resistance to watch stands at $10.28. Second resistance stands at $10.49. The third major resistance level sits at $10.88. If the price goes on to break the first support level at $9.68, it is likely to go to the next support level at $9.29. The third support level lies at $9.08 if the price breaches the second support level.
Wave Life Sciences Ltd (NASDAQ: WVE) Key Stats
The company with the Market Capitalisation of 1.55 billion has total of 153,486K Shares Outstanding. Its annual sales at the moment are 108,300 K in contrast with the sum of -97,010 K annual income. Company’s last quarter sales were recorded 83,750 K and last quarter income was 29,250 K.
